Abbott Laboratories · NYSE:ABT
Boudreau Philip P bought 2,200 Abbott Laboratories shares (Form 4)
Traded Apr 23, 2026 · Filed Apr 27, 2026
On Apr 23, 2026, Boudreau Philip P (EVP AND CFO) bought 2,200 Abbott Laboratories shares at US$91.50 for US$201K, leaving 2,200 shares. Filed Apr 27, 2026 (Form 4).
- Bought
- 2,200 shares
- Price
- US$91.50
- Value
- US$201K
- Holding after
- 2,200 shares (held indirectly)
- Trading plan
- No
- Role
- EVP AND CFO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 23, 2026 | Common shares without par value | Other | 8,909 | US$92.04 | 9,276 | Indirect |
| Apr 23, 2026 | Common shares without par value | Buy | 2,200 | US$91.50 | 2,200 | Indirect |
Source
Related
- Abbott Laboratories
- Boudreau Philip P
- Abbott Laboratories shareholders
- Form 4 · Boudreau Philip P · Sep 3, 2026
- Form 4 · Conroy Kevin T · Sep 25, 2026
- Form 4 · McCoy John A. Jr. · Sep 3, 2026
- Form 4 · Ford Robert B · Aug 27, 2026
- Form 4 · Morrone Louis H. · Aug 13, 2026
- Form 4 · Morrone Louis H. · Jul 1, 2026